Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159197835> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W3159197835 endingPage "42" @default.
- W3159197835 startingPage "35" @default.
- W3159197835 abstract "Inflammation, insulin resistance and oxidative stress (OS), are among the mechanisms that have been implicated in pathogenesis of essential hypertension (EH). Peripheral polymorphonuclear leukocytes (PMNLs) are primed in EH patients, releasing uncontrolled superoxide anion contributing to OS in these patients. PMNL priming correlates with insulin resistance and with PMNL intracellular calcium ([Ca2+]i). Recent studies have attributed to the anti-hypertensive drug lercanidipine, a third generation calcium-channel blocker, and additional anti-ischemic and anti-oxidative characteristics. To evaluate the possible non-traditional effect of two months of lercanidipine treatment on insulin resistance and on PMNL-related inflammation in EH patients. Non-smoking EH patients with untreated mild to moderate high blood pressure (BP) were included. Low-graded inflammation was reflected by WBC and PMNL counts and by PMNL apoptosis. Systemic inflammation was measured by plasma fibrinogen, C-reactive protein (CRP) and albumin levels. Fasting serum insulin levels served as a marker of insulin resistance. Two months of lercanidipine treatment showed significant decrease in BP, WBC and PMNL counts, and also in PMNL apoptosis, CRP and serum insulin levels and significant increase in serum albumin levels. Rates of superoxide release from PMNLs, WBC and PMNL counts and insulin levels positively correlated with mean arterial blood pressure values. We imply that use of lercanidipine can be favored in EH patients due to its combined anti-PMNL priming and anti-inflammatory effects, in addition to its anti-hypertensive characteristics. Key words: Essential hypertension, lercanidipine, low-graded inflammation, primed polymorphonuclear leukocytes, oxidative stress." @default.
- W3159197835 created "2021-05-10" @default.
- W3159197835 creator A5003935367 @default.
- W3159197835 creator A5044556051 @default.
- W3159197835 date "2013-02-28" @default.
- W3159197835 modified "2023-09-27" @default.
- W3159197835 title "Lercanidipine effect on polymorphonuclear leukocyte-related inflammation and insulin resistance in essential hypertension patients" @default.
- W3159197835 doi "https://doi.org/10.5897/ijmms12.087" @default.
- W3159197835 hasPublicationYear "2013" @default.
- W3159197835 type Work @default.
- W3159197835 sameAs 3159197835 @default.
- W3159197835 citedByCount "0" @default.
- W3159197835 crossrefType "journal-article" @default.
- W3159197835 hasAuthorship W3159197835A5003935367 @default.
- W3159197835 hasAuthorship W3159197835A5044556051 @default.
- W3159197835 hasConcept C126322002 @default.
- W3159197835 hasConcept C134018914 @default.
- W3159197835 hasConcept C2776151105 @default.
- W3159197835 hasConcept C2776914184 @default.
- W3159197835 hasConcept C2777097880 @default.
- W3159197835 hasConcept C2777391703 @default.
- W3159197835 hasConcept C2779283177 @default.
- W3159197835 hasConcept C2779306644 @default.
- W3159197835 hasConcept C71924100 @default.
- W3159197835 hasConcept C84393581 @default.
- W3159197835 hasConcept C98274493 @default.
- W3159197835 hasConceptScore W3159197835C126322002 @default.
- W3159197835 hasConceptScore W3159197835C134018914 @default.
- W3159197835 hasConceptScore W3159197835C2776151105 @default.
- W3159197835 hasConceptScore W3159197835C2776914184 @default.
- W3159197835 hasConceptScore W3159197835C2777097880 @default.
- W3159197835 hasConceptScore W3159197835C2777391703 @default.
- W3159197835 hasConceptScore W3159197835C2779283177 @default.
- W3159197835 hasConceptScore W3159197835C2779306644 @default.
- W3159197835 hasConceptScore W3159197835C71924100 @default.
- W3159197835 hasConceptScore W3159197835C84393581 @default.
- W3159197835 hasConceptScore W3159197835C98274493 @default.
- W3159197835 hasIssue "2" @default.
- W3159197835 hasLocation W31591978351 @default.
- W3159197835 hasOpenAccess W3159197835 @default.
- W3159197835 hasPrimaryLocation W31591978351 @default.
- W3159197835 hasRelatedWork W115952786 @default.
- W3159197835 hasRelatedWork W171752692 @default.
- W3159197835 hasRelatedWork W1787140015 @default.
- W3159197835 hasRelatedWork W2004750382 @default.
- W3159197835 hasRelatedWork W2021908911 @default.
- W3159197835 hasRelatedWork W2055707379 @default.
- W3159197835 hasRelatedWork W2063944578 @default.
- W3159197835 hasRelatedWork W2074586251 @default.
- W3159197835 hasRelatedWork W2079092493 @default.
- W3159197835 hasRelatedWork W2085732390 @default.
- W3159197835 hasRelatedWork W2114156087 @default.
- W3159197835 hasRelatedWork W2115492929 @default.
- W3159197835 hasRelatedWork W2170652400 @default.
- W3159197835 hasRelatedWork W2188775829 @default.
- W3159197835 hasRelatedWork W2274285516 @default.
- W3159197835 hasRelatedWork W2360061877 @default.
- W3159197835 hasRelatedWork W2388212478 @default.
- W3159197835 hasRelatedWork W2566760646 @default.
- W3159197835 hasRelatedWork W2996300020 @default.
- W3159197835 hasRelatedWork W3039101667 @default.
- W3159197835 hasVolume "5" @default.
- W3159197835 isParatext "false" @default.
- W3159197835 isRetracted "false" @default.
- W3159197835 magId "3159197835" @default.
- W3159197835 workType "article" @default.